United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - thalidomide - tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - thalidomide - tablet - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - thalidomide - tablet - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - thalidomide - oral suspension - 20mg/1ml

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع البتراء للمواد الطبية - petra drug store - thalidomide 50 mg - 50 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - thalidomide 100mg - capsule - 100 mg - active: thalidomide 100mg excipient: gelatin magnesium stearate pregelatinised maize starch - · thalomid in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma aged 65 years or older, or ineligible for high dose chemotherapy. · thalomid in combination with dexamethasone is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue, for the treatment of patients with untreated multiple myeloma. ·thalomid, as monotherapy, is indicated for the treatment of multiple myeloma after failure of standard therapies.

New Zealand - English - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - thalidomide 150mg - capsule - 150 mg - active: thalidomide 150mg excipient: gelatin magnesium stearate pregelatinised maize starch - · thalomid in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma aged 65 years or older, or ineligible for high dose chemotherapy. · thalomid in combination with dexamethasone is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue, for the treatment of patients with untreated multiple myeloma. ·thalomid, as monotherapy, is indicated for the treatment of multiple myeloma after failure of standard therapies.

New Zealand - English - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - thalidomide 200mg - capsule - 200 mg - active: thalidomide 200mg excipient: gelatin magnesium stearate pregelatinised maize starch - · thalomid in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma aged 65 years or older, or ineligible for high dose chemotherapy. · thalomid in combination with dexamethasone is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue, for the treatment of patients with untreated multiple myeloma. ·thalomid, as monotherapy, is indicated for the treatment of multiple myeloma after failure of standard therapies.

New Zealand - English - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - thalidomide 50mg - capsule - 50 mg - active: thalidomide 50mg excipient: gelatin magnesium stearate pregelatinised maize starch - · thalomid in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma aged 65 years or older, or ineligible for high dose chemotherapy. · thalomid in combination with dexamethasone is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue, for the treatment of patients with untreated multiple myeloma. ·thalomid, as monotherapy, is indicated for the treatment of multiple myeloma after failure of standard therapies.

Canada - English - Health Canada

celgene inc - thalidomide - capsule - 50mg - thalidomide 50mg - immunomodulatory agents